Overview
Teratoma of the central nervous system (CNS teratoma) is a rare germ cell tumor that arises within the brain or spinal cord. Teratomas are composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain differentiated structures such as hair, teeth, bone, cartilage, and glandular tissue. CNS teratomas are classified as mature (benign), immature (potentially malignant), or teratoma with malignant transformation. They most commonly occur in the midline structures of the brain, particularly the pineal region and the suprasellar area, though they can also arise in the posterior fossa or spinal cord. Symptoms depend on the tumor's location and size. Pineal region teratomas frequently cause obstructive hydrocephalus, leading to headaches, nausea, vomiting, and visual disturbances such as Parinaud syndrome (impaired upward gaze). Suprasellar teratomas may present with endocrine dysfunction, including diabetes insipidus, growth hormone deficiency, and precocious or delayed puberty. Other symptoms can include seizures, focal neurological deficits, and signs of increased intracranial pressure. In neonates and infants, CNS teratomas may present with macrocephaly and developmental delay. CNS teratomas occur predominantly in children and young adults, with a male predominance, particularly for pineal region tumors. Diagnosis involves neuroimaging (MRI/CT), measurement of serum and cerebrospinal fluid tumor markers (alpha-fetoprotein and beta-hCG), and histopathological examination. Treatment typically involves surgical resection, which is often curative for mature teratomas. Immature teratomas or those with malignant components may require adjuvant chemotherapy and/or radiotherapy. The prognosis for mature teratomas is generally favorable following complete surgical excision, while immature teratomas and those with malignant transformation carry a more guarded prognosis.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventThalomid: FDA approved
Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableThalomid
Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL r…
Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.
Clinical Trials
View all trials with filters →No actively recruiting trials found for Teratoma of the central nervous system at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Teratoma of the central nervous system.
Community
No community posts yet. Be the first to share your experience with Teratoma of the central nervous system.
Start the conversation →Latest news about Teratoma of the central nervous system
No recent news articles for Teratoma of the central nervous system.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Teratoma of the central nervous system
What is Teratoma of the central nervous system?
Teratoma of the central nervous system (CNS teratoma) is a rare germ cell tumor that arises within the brain or spinal cord. Teratomas are composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain differentiated structures such as hair, teeth, bone, cartilage, and glandular tissue. CNS teratomas are classified as mature (benign), immature (potentially malignant), or teratoma with malignant transformation. They most commonly occur in the midline structures of the brain, particularly the pineal region and the suprasellar area, though th
How is Teratoma of the central nervous system inherited?
Teratoma of the central nervous system follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Teratoma of the central nervous system?
10 specialists and care centers treating Teratoma of the central nervous system are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.